Literature DB >> 20353308

High recovery of mesenchymal progenitor cells with non-density gradient separation of human bone marrow.

Simone Dal Pozzo1, Serena Urbani, Benedetta Mazzanti, Paola Luciani, Cristiana Deledda, Letizia Lombardini, Susanna Benvenuti, Alessandro Peri, Alberto Bosi, Riccardo Saccardi.   

Abstract

BACKGROUND AIMS: Bone marrow (BM) is the most used source of hemopoietic stem cells (HSC) and mesenchymal stromal cells (MSC) in both hematologic settings and regenerative medicine. We compared the feasibility and reproducibility of two gravity separation techniques, with or without the use of a density gradient, in terms of both hematopoietic and mesenchymal human BM progenitors.
METHODS: A total of 16 BM samples was processed to obtain mononuclear cells (MNC) and buffy coats (BC). The efficiency of the two procedures was evaluated by recovery of white blood cells (WBC), MNC and CD34(+) cells, clonogenic assays, red blood cell (RBC) depletion, cell viability, expression of embryonic transcriptional regulators and MSC assessment.
RESULTS: The two procedures yielded a comparable recovery of HSC. Non-density gradient separation (NDGS) of BM resulted in four times higher MSC recovery and higher expression of embryonic stem cell markers (Nanog and Sox2) compared with density-gradient separation (DGS). MSC derived from both procedures was comparable in terms of phenotype, differentiation and proliferation potential.
CONCLUSIONS: NDGS is less time consuming, provides a better MSC enrichment and appears to be a suitable cell preparation method for clinical applications.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20353308     DOI: 10.3109/14653241003709660

Source DB:  PubMed          Journal:  Cytotherapy        ISSN: 1465-3249            Impact factor:   5.414


  5 in total

1.  Fully automated, clinical-grade bone marrow processing: a single-centre experience.

Authors:  Benedetta Mazzanti; Serena Urbani; Simone Dal Pozzo; Paola Bufano; Lara Ballerini; Alessia Gelli; Irene Sodi; Irene Donnini; Massimo Di Gioia; Stefano Guidi; Julien Camisani; Riccardo Saccardi
Journal:  Blood Transfus       Date:  2016-09-27       Impact factor: 3.443

2.  SOX2 has a crucial role in the lineage determination and proliferation of mesenchymal stem cells through Dickkopf-1 and c-MYC.

Authors:  S B Park; K W Seo; A Y So; M S Seo; K R Yu; S K Kang; K S Kang
Journal:  Cell Death Differ       Date:  2011-10-21       Impact factor: 15.828

3.  Vertebral body versus iliac crest bone marrow as a source of multipotential stromal cells: Comparison of processing techniques, tri-lineage differentiation and application on a scaffold for spine fusion.

Authors:  Evangelos M Fragkakis; Jehan Jomaa El-Jawhari; Robert A Dunsmuir; Peter A Millner; Abhay S Rao; Karen T Henshaw; Ippokratis Pountos; Elena Jones; Peter V Giannoudis
Journal:  PLoS One       Date:  2018-05-24       Impact factor: 3.240

Review 4.  Bone Marrow Multipotent Mesenchymal Stromal Cells as Autologous Therapy for Osteonecrosis: Effects of Age and Underlying Causes.

Authors:  Jehan J El-Jawhari; Payal Ganguly; Elena Jones; Peter V Giannoudis
Journal:  Bioengineering (Basel)       Date:  2021-05-17

5.  The CD45lowCD271high Cell Prevalence in Bone Marrow Samples May Provide a Useful Measurement of the Bone Marrow Quality for Cartilage and Bone Regenerative Therapy.

Authors:  Jehan J El-Jawhari; Richard Cuthbert; Dennis McGonagle; Elena Jones; Peter V Giannoudis
Journal:  J Bone Joint Surg Am       Date:  2017-08-02       Impact factor: 5.284

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.